After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, AXGN falls under the Healthcare sector while operating within the Medical Devices industry segment. The current market capitalization of Axogen Inc is $1.51B. A total of 0.69 million shares were traded on the day, compared to an average of 886.74K shares.
In the most recent transaction, Wendell Amy McBride sold 43,684 shares of AXGN for 29.31 per share on Dec 16 ’25. After the transaction, the Director now owns 93,826 company shares. In a previous transaction on Dec 16 ’25, Weiler Kathy Johnson sold 46,653 shares at 29.55 per share. AXGN shares that Director owns now total 0.
Among the insiders who sold shares, Hartley Lindsey Marie disposed of 14,812 shares on Dec 15 ’25 at a per-share price of $29.86. This resulted in the CFO holding 31,376 shares of AXGN after the transaction. In another insider transaction, Amy McBride-Wendell bought 43,684 shares at $29.31 per share on Dec 16 ’25.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, AXGN has a high of $34.24 and a low of $9.22.
As of this writing, AXGN has an earnings estimate of $0.06 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of $0.1 per share and a lower estimate of $0.04. The company reported an EPS of $0.07 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. AXGN’s latest balance sheet shows that the firm has $84.09M in Cash & Short Term Investments as of fiscal 2021. There were $67.45M in debt and $24.29M in liabilities at the time. Its Book Value Per Share was $2.62, while its Total Shareholder’s Equity was $112.55M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AXGN is Buy with a score of 4.70.
